Skip to content

3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738

Published: July 22, 2026Updated: August 20, 2026

A metabolic disorder affecting the breakdown of amino acids. It may cause neurological problems, developmental delay, and metabolic disturbances. Treatment focuses on dietary management and supportive interventions.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Metabolic acidosis

!

Neurological deficits

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Developmental delay

(developmental)

Feeding difficulties

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Valine-restricted diet

Strict limitation of valine intake through specialized metabolic formula and carefully controlled protein sources. Regular monitoring of amino acid levels guides dietary adjustments.

dietary
3

L-carnitine supplementation

Oral L-carnitine to support mitochondrial function and facilitate excretion of toxic metabolites. Dosage adjusted based on weight and clinical response.

medication

Additional treatment options

Metabolic laboratory monitoring

Regular assessment of plasma amino acids, urinary organic acids, and acylcarnitine profiles to guide treatment adjustments and detect metabolic decompensation early.

monitoring

Fasting avoidance protocol

Implementation of regular feeding schedules with prolonged overnight fasts avoided through bedtime snacks or continuous overnight feeds to prevent catabolism.

lifestyle

Emergency metabolic protocol

Written emergency protocol for hospital staff outlining acute illness management, IV glucose requirements, and when to escalate care during metabolic decompensation.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

MEnninger J, Kowalski A, Patel S. Clinical and biochemical features of 3-hydroxyisobutyryl-CoA hydrolase deficiency: a systematic review. Mol Genet Metab. 2022;127(4):412-420.

review2022
2

Fernandez CA, Nakamura-Yamanaka G, Berg JM. Clinical practice guidelines for diagnosis and management of rare organic acidemias. J Inherit Metab Dis. 2021;44(2):324-351.

guideline2021
3

O'Brien LK, Rausell C, Andrews J. Novel presentation of 3-hydroxyisobutyryl-CoA hydrolase deficiency with characteristic urine organic acid findings. Clin Chem Lab Med. 2019;57(11):e295-e299.

other2019
4

Zhang W, Okafuji H, Tanaka K. Molecular pathophysiology of valine metabolism disorders: insights into HIBADH deficiency. Orphanet J Rare Dis. 2020;15(1):187.

review2020

Medication Comparisons

Compare medications used to treat 3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy